You can now read 5 articles in a month for free on BostonGlobe.com. Read as much as you want anywhere and anytime for just 99¢.

Mass. Movers

Charles River’s 2013 forecast disappoints

Charles River’s business includes selling lab mice.

Globe file photo/2006

Charles River’s business includes selling lab mice.

Continue reading below

Charles River Laboratories International Inc., which provices drug-research services, gave 2013 earnings guidance that was below Wall Street’s expectations. In addition, the Wilmington company now expects its 2012 per-share earnings to come in between the low end and the midpoint of its previously estimated range of $2.68 to $2.73. The company expects sales to grow by 3 to 5 percent next year, and that non-GAAP earnings per share would be in the range of $2.80 to $2.90. The analyst consensus for 2013 is $3.02, RTTNews reported.

Loading comments...
Want each day's news headlines delivered fresh to your
inbox every morning? Just connect with us
in one of the following ways:
or
Please enter a valid email
BostonGlobe.com will never post anything without asking.
Privacy Policy
Subscriber Log In

You have reached the limit of 5 free articles in a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of BostonGlobe.com
Marketing image of BostonGlobe.com